These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 7192139)

  • 1. Characterization of a new potent heparin. 3rd Communication: Determinations of anticoagulant activity of a new potent heparin preparation by thrombelastography in vitro using citrated dog and human blood.
    Bhargava AS; Freihube G; Günzel P
    Arzneimittelforschung; 1980; 30(8):1256-8. PubMed ID: 7192139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of a new potent heparin. 1 communication: Determinations of anticoagulant activity of a high potency heparin preparation in vivo using dog as an experimental animal and in vitro using dog and human plasma.
    Bhargava AS; Heinick J; Schöbel C; Günzel P
    Arzneimittelforschung; 1980; 30(6):993-6. PubMed ID: 7191280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of a new potent heparin. 6th communication: The comparison of the anticoagulant effect of the sodium and calcium salts of a new potent heparin after s.c. injection in beagle dogs.
    Bhargava AS; Schöbel C; Günzel P
    Arzneimittelforschung; 1981; 31(1):79-82. PubMed ID: 7194097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of a new potent heparin. 7th communication: A comparative study of a new potent heparin in human after i.v. application.
    Bhargava AS; Wendt H; Günzel P
    Arzneimittelforschung; 1981; 31(2):386-8. PubMed ID: 7194658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The influence of the Soviet antimalarial preparation dabequin on the hemostatic system and on the anticoagulant effect of heparin].
    Pomortseva IV; Ovchinnikova LK; Shcheglova NV
    Farmakol Toksikol; 1990; 53(1):59-62. PubMed ID: 2328805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of a new potent heparin. 4th communication: The effect of a new potent heparin preparation on lipid components and leucocytes in rats after subcutaneous application.
    Bhargava AS; Staben P; Schöbel C; Günzel P
    Arzneimittelforschung; 1980; 30(9):1562-6. PubMed ID: 7193025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of a new potent heparin. 5th Communication: Further characterization by affinity chromatography on antithrombin-sepharose and its comparison with a commercially available heparin.
    Bhargava AS; Freihube G; Günzel P
    Arzneimittelforschung; 1980; 30(10):1621-3. PubMed ID: 7192096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of blood cell activation by four commonly used anticoagulants.
    Engstad CS; Gutteberg TJ; Osterud B
    Thromb Haemost; 1997 Apr; 77(4):690-6. PubMed ID: 9134644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticoagulant mechanisms of covalent antithrombin-heparin investigated by thrombelastography. Comparison with unfractionated heparin and low-molecular-weight heparin.
    Atkinson HM; Mewhort-Buist TA; Berry LR; Chan AK
    Thromb Haemost; 2009 Jul; 102(1):62-8. PubMed ID: 19572069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of kaolin-activated versus nonkaolin-activated thromboelastography in native and citrated blood.
    Thalheimer U; Triantos CK; Samonakis DN; Zambruni A; Senzolo M; Leandro G; Patch D; Burroughs AK
    Blood Coagul Fibrinolysis; 2008 Sep; 19(6):495-501. PubMed ID: 18685432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Influence of nonachlazin, riboxin and isoptin on the blood coagulation system and the anticoagulant effect of heparin].
    Shevchenko LV; Ovchinnikova LK; Zolotukhin SI
    Farmakol Toksikol; 1980; 43(4):389-95. PubMed ID: 7439373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The significance of TFPI in clotting assays--comparison and combination with other anticoagulants.
    Nordfang O; Kristensen HI; Valentin S; Ostergaard P; Wadt J
    Thromb Haemost; 1993 Sep; 70(3):448-53. PubMed ID: 8259547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of new synthetic heparin mimetics on whole blood thrombin generation in vivo and in vitro in rats.
    Hérault JP; Bernat A; Gaich C; Herbert M
    Thromb Haemost; 2002 Feb; 87(2):238-44. PubMed ID: 11858483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of citrated whole blood transfusion in response to hemorrhage.
    Blumenthal SR; Williams TC; Barbee RW; Watts JA; Gordon BE
    Lab Anim Sci; 1999 Aug; 49(4):411-7. PubMed ID: 10480647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of glycosaminoglycans on coagulation: a thromboelastographic study.
    Senzolo M; Coppell J; Cholongitas E; Riddell A; Triantos CK; Perry D; Burroughs AK
    Blood Coagul Fibrinolysis; 2007 Apr; 18(3):227-36. PubMed ID: 17413758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rotational thrombelastometry for the bedside monitoring of recombinant hirudin.
    Sucker C; Zotz RB; Görlinger K; Hartmann M
    Acta Anaesthesiol Scand; 2008 Mar; 52(3):358-62. PubMed ID: 18205897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant activated factor VII effectively reverses the anticoagulant effects of heparin, enoxaparin, fondaparinux, argatroban, and bivalirudin ex vivo as measured using thromboelastography.
    Young G; Yonekawa KE; Nakagawa PA; Blain RC; Lovejoy AE; Nugent DJ
    Blood Coagul Fibrinolysis; 2007 Sep; 18(6):547-53. PubMed ID: 17762530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thromboelastography assessment of coagulation status in parturients with lupus anticoagulant receiving heparin therapy.
    Harnett M; Kodali BS
    Int J Obstet Anesth; 2006 Apr; 15(2):177-8. PubMed ID: 16488131
    [No Abstract]   [Full Text] [Related]  

  • 19. The effect of heparin versus citrate on blood echogenicity in vitro: the role of platelet and platelet-neutrophil aggregates.
    Mahony C; Ferguson J
    Ultrasound Med Biol; 1992; 18(10):851-9. PubMed ID: 1481287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Potentiation of the anticoagulant effects of a phosphatidylserine-containing anticoagulant and heparin].
    Byshevskiĭ ASh; Sokolovskiĭ SR
    Vopr Med Khim; 1982; 28(2):30-4. PubMed ID: 7080476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.